Greenleaf Trust raised its position in Stericycle Inc (NASDAQ:SRCL) by 16.7% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 11,957 shares of the business services provider’s stock after buying an additional 1,712 shares during the quarter. Greenleaf Trust’s holdings in Stericycle were worth $813,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. NEXT Financial Group Inc boosted its position in shares of Stericycle by 77.9% in the 3rd quarter. NEXT Financial Group Inc now owns 2,322 shares of the business services provider’s stock worth $164,000 after buying an additional 1,017 shares in the last quarter. Balter Liquid Alternatives LLC purchased a new stake in shares of Stericycle in the 4th quarter worth about $206,000. ARGI Investment Services LLC purchased a new stake in shares of Stericycle in the 3rd quarter worth about $215,000. Zions Bancorporation purchased a new stake in shares of Stericycle in the 3rd quarter worth about $233,000. Finally, Cadence Capital Management LLC purchased a new stake in shares of Stericycle in the 3rd quarter worth about $234,000. 94.24% of the stock is currently owned by institutional investors.
Shares of Stericycle Inc (NASDAQ:SRCL) opened at $74.29 on Thursday. The stock has a market cap of $6,161.36, a P/E ratio of 16.63, a P/E/G ratio of 1.75 and a beta of 0.26. Stericycle Inc has a 1 year low of $61.25 and a 1 year high of $88.00. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.93.
A number of research firms have issued reports on SRCL. BidaskClub lowered shares of Stericycle from a “hold” rating to a “sell” rating in a report on Thursday, January 11th. Zacks Investment Research raised shares of Stericycle from a “sell” rating to a “hold” rating in a research note on Wednesday, January 10th. BMO Capital Markets reaffirmed a “hold” rating and set a $72.00 price objective on shares of Stericycle in a research note on Wednesday, January 24th. Royal Bank of Canada dropped their price objective on shares of Stericycle from $74.00 to $67.00 and set an “underperform” rating for the company in a research note on Thursday, November 9th. Finally, Robert W. Baird raised shares of Stericycle from an “underperform” rating to a “neutral” rating and set a $73.00 price objective for the company in a research note on Tuesday. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and five have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $73.70.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.